+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biotechnology Instruments Market Size, Share & Trends Analysis Report By Product (Cell Culture Instruments, Analytical Instruments), By End-use (Pharma & Biotech Companies, Academic & Research Institutes), And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 5450218
The global biotechnology instruments market size is expected to reach USD 116.68 billion by 2030., exhibiting a CAGR of 3.94% from 2023 to 2030. The growing advancements in life science research technologies, growing demand for personalized medicines & diagnostics tests, and rising R&D for drug & vaccine developments for diseases, such as cancer, collectively propel the market growth. The demand for POC diagnostics is projected to be driven by factors, such as increasing government initiatives to establish outpatient care models for shortening hospital stays and the rising need for POC devices in home & healthcare settings to address the needs of the elderly population.

In addition, the expansion of the biotechnology industry can be linked to various factors including the introduction of new & innovative products, agreements, acquisitions, technological advancements, and growing adoption across different applications. In May 2023, NeoDx Biotech Labs, an Indian startup, launched 7 real-time PCR-based kits to diagnose infectious diseases, such as Hepatitis C, Hepatitis B, and HIV, at various hospitals and diagnostic centers. Similarly, in January 2023, Bio-Rad announced the launch of a real-time PCR system, CFX Opus Deepwell Dx, which is FDA-approved for IVD testing. Thus, these technological launches are projected to impel the market growth over the period. In addition, companies are launching new products to facilitate better and more advanced sequencing technology.

For instance, in April 2023, Biomodal, formerly known as Cambridge Epigenetix, announced the launch of the duet multiomics solution. This new multiomics sequencing technology is projected to highlight the synergistic potential of genetic and epigenetic insights extracted from a single low-volume sample. Moreover, the solution is one of the first single-base-resolution sequencing technologies, which enables simultaneous, phased reading of both genetic and epigenetic details from a single sample. This increases applications of the technology in unified workflows alongside any sequencing platforms. The increasing adoption of technological advancements in sequencing techniques is anticipated to impel market growth.

Biotechnology Instruments Market Report Highlights

  • Based on product, the analytical instruments segment dominated the market in 2022 with a share of 61.92%
  • The growing demand for advanced drug development, biomarker discovery, and quality control across pharmaceuticals is anticipated to fuel the segment growth over the forecast period
  • Based on end-use, the pharmaceutical & biotechnological companies segment held the largest market share of 38.10% in 2022
  • This can be attributed to the increased number of drug therapies for various diseases, such as cancer, vaccine developments, and designing diagnostic tools for disease monitoring & detection
  • In 2022, North America dominated the market with a share of 43.95% owing to the presence of major players and robust healthcare infrastructure


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Biotechnology Instruments Market

What is the estimated value of the Global Biotechnology Instruments Market?

The Global Biotechnology Instruments Market was estimated to be valued at $86.28 Billion in 2022.

What is the growth rate of the Global Biotechnology Instruments Market?

The growth rate of the Global Biotechnology Instruments Market is 3.9%, with an estimated value of $116.68 Billion by 2030.

What is the forecasted size of the Global Biotechnology Instruments Market?

The Global Biotechnology Instruments Market is estimated to be worth $116.68 Billion by 2030.

Who are the key companies in the Global Biotechnology Instruments Market?

Key companies in the Global Biotechnology Instruments Market include Thermo Fisher Scientific, Inc., Waters Corp., Shimadzu Corp., Danaher, Agilent Technologies, Inc., Bruker Corp., PerkinElmer, Inc., Mettler Toledo, Zeiss Group and Bio.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. End-use Segment
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
1.9.3. Objective 3
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends And Outlook
3.3. Market Dynamics
3.3.1. Increasing Demand For Analytical Instruments
3.3.2. Growing Prevalence Of Target Diseases And Rising Geriatric Population
3.3.3. Technological Advancements In Research-Use Instruments
3.4. Market Restraint Analysis
3.4.1. Higher Cost Of Devices
3.4.2. Shortage Of Skilled Professionals
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Biotechnology Instruments Market: Product Movement Analysis
4.2. Analytical Instruments
4.2.1. Analytical Instruments Market, 2018 - 2030 (USD Million)
4.2.2. Polymerase Chain Reaction
4.2.2.1. Polymerase Chain Reaction, 2018 - 2030 (USD Million)
4.2.3. Spectroscopy
4.2.3.1. Spectroscopy, 2018 - 2030 (USD Million)
4.2.4. Microscopy
4.2.4.1. Microscopy, 2018 - 2030 (USD Million)
4.2.5. Chromatography
4.2.5.1. Chromatography, 2018 - 2030 (USD Million)
4.2.6. Flow Cytometry
4.2.6.1. Flow Cytometry, 2018 - 2030 (USD Million)
4.2.7. Sequencing
4.2.7.1. Sequencing, 2018 - 2030 (USD Million)
4.2.8. Microarray
4.2.8.1. Microarray, 2018 - 2030 (USD Million)
4.2.9. Others
4.2.9.1. Others, 2018 - 2030 (USD Million)
4.3. Cell Culture Instruments
4.3.1. Cell Culture Instruments Market, 2018 - 2030 (USD Million)
4.3.2. Culture Systems
4.3.2.1. Culture Systems Market, 2018 - 2030 (USD Million)
4.3.3. Incubators
4.3.3.1. Incubators Market, 2018 - 2030 (USD Million)
4.3.4. Cryostorage Equipment
4.3.4.1. Cryostorage Equipment Market, 2018 - 2030 (USD Million)
4.3.5. Biosafety Equipment
4.3.5.1. Biosafety Equipment Market, 2018 - 2030 (USD Million)
4.3.6. Pipetting Instruments
4.3.6.1. Pipetting Instruments Market, 2018 - 2030 (USD Million)
4.4. Cell Separation Instruments
4.4.1. Cell Separation Instruments Market, 2018 - 2030 (USD Million)
4.4.2. Centrifuge
4.4.2.1. Centrifuge Market, 2018 - 2030 (USD Million)
4.4.3. Filtration Systems
4.4.3.1. Filtration Systems Market, 2018 - 2030 (USD Million)
4.4.4. Magnetic-activated Cell Separator Systems
4.4.4.1. Magnetic-activated Cell Separator Systems Market, 2018 - 2030 (USD Million)
4.5. Immunoassay Instruments
4.5.1. Immunoassay Instruments Market, 2018 - 2030 (USD Million)
4.6. Clinical Chemistry Analyzers
4.6.1. Clinical Chemistry Analyzers Market, 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. End-use Business Analysis
5.1. Biotechnology Instruments Market: End-use Movement Analysis
5.2. Pharmaceutical & Biotechnology Companies
5.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
5.3. Hospitals & Diagnostic Laboratories
5.3.1. Hospitals & Diagnostics Laboratories Market, 2018 - 2030 (USD Million)
5.4. Academic & Research Institutes
5.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Regional Market Snapshot
6.2. North America
6.2.1. North America Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.2.2.2. Key Country Dynamics
6.2.2.3. Competitive Scenario
6.2.2.4. Target Disease Prevalence
6.2.2.5. Regulatory Framework
6.2.3. Canada
6.2.3.1. Canada Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.2.3.2. Key Country Dynamics
6.2.3.3. Competitive Scenario
6.2.3.4. Target Disease Prevalence
6.2.3.5. Regulatory Framework
6.3. Europe
6.3.1. Europe Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. UK Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.3.2.2. Key Country Dynamics
6.3.2.3. Competitive Scenario
6.3.2.4. Target Disease Prevalence
6.3.2.5. Regulatory Framework
6.3.3. Germany
6.3.3.1. Germany Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.3.3.2. Key Country Dynamics
6.3.3.3. Competitive Scenario
6.3.3.4. Target Disease Prevalence
6.3.3.5. Regulatory Framework
6.3.4. Spain
6.3.4.1. Spain Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.3.4.2. Key Country Dynamics
6.3.4.3. Competitive Scenario
6.3.4.4. Target Disease Prevalence
6.3.4.5. Regulatory Framework
6.3.5. France
6.3.5.1. France Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.3.5.2. Key Country Dynamics
6.3.5.3. Competitive Scenario
6.3.5.4. Target Disease Prevalence
6.3.5.5. Regulatory Framework
6.3.6. Italy
6.3.6.1. Italy Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.3.6.2. Key Country Dynamics
6.3.6.3. Competitive Scenario
6.3.6.4. Target Disease Prevalence
6.3.6.5. Regulatory Framework
6.3.7. Denmark
6.3.7.1. Denmark Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.3.7.2. Key Country Dynamics
6.3.7.3. Competitive Scenario
6.3.7.4. Target Disease Prevalence
6.3.7.5. Regulatory Framework
6.3.8. Sweden
6.3.8.1. Sweden Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.3.8.2. Key Country Dynamics
6.3.8.3. Competitive Scenario
6.3.8.4. Target Disease Prevalence
6.3.8.5. Regulatory Framework
6.3.9. Norway
6.3.9.1. Norway Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.3.9.2. Key Country Dynamics
6.3.9.3. Competitive Scenario
6.3.9.4. Target Disease Prevalence
6.3.9.5. Regulatory Framework
6.4. Asia Pacific
6.4.1. Asia-Pacific Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Japan Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.4.2.2. Key Country Dynamics
6.4.2.3. Competitive Scenario
6.4.2.4. Target Disease Prevalence
6.4.2.5. Regulatory Framework
6.4.3. China
6.4.3.1. China Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.4.3.2. Key Country Dynamics
6.4.3.3. Competitive Scenario
6.4.3.4. Target Disease Prevalence
6.4.3.5. Regulatory Framework
6.4.4. India
6.4.4.1. India Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.4.4.2. Key Country Dynamics
6.4.4.3. Competitive Scenario
6.4.4.4. Target Disease Prevalence
6.4.4.5. Regulatory Framework
6.4.5. South Korea
6.4.5.1. South Korea Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.4.5.2. Key Country Dynamics
6.4.5.3. Competitive Scenario
6.4.5.4. Target Disease Prevalence
6.4.5.5. Regulatory Framework
6.4.6. Thailand
6.4.6.1. Thailand Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.4.6.2. Key Country Dynamics
6.4.6.3. Competitive Scenario
6.4.6.4. Target Disease Prevalence
6.4.6.5. Regulatory Framework
6.4.7. Australia
6.4.7.1. Australia Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.4.7.2. Key Country Dynamics
6.4.7.3. Competitive Scenario
6.4.7.4. Target Disease Prevalence
6.4.7.5. Regulatory Framework
6.5. Latin America
6.5.1. Latin America Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.5.2.2. Key Country Dynamics
6.5.2.3. Competitive Scenario
6.5.2.4. Target Disease Prevalence
6.5.2.5. Regulatory Framework
6.5.3. Mexico
6.5.3.1. Mexico Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.5.3.2. Key Country Dynamics
6.5.3.3. Competitive Scenario
6.5.3.4. Target Disease Prevalence
6.5.3.5. Regulatory Framework
6.5.4. Argentina
6.5.4.1. Argentina Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.5.4.2. Key Country Dynamics
6.5.4.3. Competitive Scenario
6.5.4.4. Target Disease Prevalence
6.5.4.5. Regulatory Framework
6.6. MEA
6.6.1. MEA Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. South Africa Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.6.2.2. Key Country Dynamics
6.6.2.3. Competitive Scenario
6.6.2.4. Target Disease Prevalence
6.6.2.5. Regulatory Framework
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.6.3.2. Key Country Dynamics
6.6.3.3. Competitive Scenario
6.6.3.4. Target Disease Prevalence
6.6.3.5. Regulatory Framework
6.6.4. UAE
6.6.4.1. UAE Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.6.4.2. Key Country Dynamics
6.6.4.3. Competitive Scenario
6.6.4.4. Target Disease Prevalence
6.6.4.5. Regulatory Framework
6.6.5. Kuwait
6.6.5.1. Kuwait Biotechnology Instruments Market, 2018 - 2030 (USD Million)
6.6.5.2. Key Country Dynamics
6.6.5.3. Competitive Scenario
6.6.5.4. Target Disease Prevalence
6.6.5.5. Regulatory Framework
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.3. Company Market Share Analysis, 2022
7.4. Company Profiles/Listing
7.4.1. Thermo Fisher Scientific, Inc.
7.4.1.1. Company Overview
7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Waters Corp.
7.4.2.1. Company Overview
7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Shimadzu Corp.
7.4.3.1. Company Overview
7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Danaher
7.4.4.1. Company Overview
7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Agilent Technologies, Inc.
7.4.5.1. Company Overview
7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Bruker Corp.
7.4.6.1. Company Overview
7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. PerkinElmer, Inc.
7.4.7.1. Company Overview
7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Mettler Toledo
7.4.8.1. Company Overview
7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Zeiss Group
7.4.9.1. Company Overview
7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Bio-Rad Laboratories, Inc.
7.4.10.1. Company Overview
7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives
7.4.11. Illumina, Inc.
7.4.11.1. Company Overview
7.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.11.3. Product Benchmarking
7.4.11.4. Strategic Initiatives
7.4.12. Eppendorf SE
7.4.12.1. Company Overview
7.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.12.3. Product Benchmarking
7.4.12.4. Strategic Initiatives
7.4.13. F. Hoffmann-La Roche AG
7.4.13.1. Company Overview
7.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.13.3. Product Benchmarking
7.4.13.4. Strategic Initiatives
7.4.14. Sartorius AG
7.4.14.1. Company Overview
7.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.14.3. Product Benchmarking
7.4.14.4. Strategic Initiatives
7.4.15. Avantor, Inc.
7.4.15.1. Company Overview
7.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.15.3. Product Benchmarking
7.4.15.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America biotechnology instruments market, by country, 2018 - 2030 (USD Million)
Table 4 North America biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 5 North America biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 7 U.S biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 8 Canada biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 9 Canada biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 10 Europe biotechnology instruments market, by country, 2018 - 2030 (USD Million)
Table 11 Europe biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 12 Europe biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 13 UK biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 14 UK biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 15 Germany biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 16 Germany biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 17 France biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 18 France biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 19 Italy biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 20 Italy biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 21 Spain biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 22 Spain biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 23 Denmark biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 24 Denmark biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 25 Sweden biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 26 Sweden biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 27 Norway biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 28 Norway biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 29 Asia Pacific biotechnology instruments market, by country, 2018 - 2030 (USD Million)
Table 30 Asia Pacific biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 31 Asia Pacific biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 32 China biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 33 China biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 34 Japan biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 35 Japan biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 36 India biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 37 India biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 38 South Korea biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 39 South Korea biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 40 Australia biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 41 Australia biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 42 Thailand biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 43 Thailand biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 44 Latin America biotechnology instruments market, by country, 2018 - 2030 (USD Million)
Table 45 Latin America biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 46 Latin America biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 47 Brazil biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 48 Brazil biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 49 Mexico biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 50 Mexico biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 51 Argentina biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 52 Argentina biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 53 Middle East & Africa biotechnology instruments market, by country, 2018 - 2030 (USD Million)
Table 54 Middle East & Africa biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 56 South Africa biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 57 South Africa biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 59 Saudi Arabia biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 60 UAE biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 61 UAE biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
Table 62 Kuwait biotechnology instruments market, by product, 2018 - 2030 (USD Million)
Table 63 Kuwait biotechnology instruments market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 Global biotechnology instruments market - Key market driver analysis
Fig. 7 Global biotechnology instruments market - Key market restraint analysis
Fig. 8 Global biotechnology instruments market - Porter’s analysis
Fig. 9 Global biotechnology instruments market - PESTEL analysis
Fig. 10 Global biotechnology instruments market: Product outlook key takeaways
Fig. 11 Global biotechnology instruments market: Product movement analysis
Fig. 12 Analytical instruments market estimates, 2018 - 2030 (USD Million)
Fig. 13 Polymerase chain reaction market estimates, 2018 - 2030 (USD Million)
Fig. 14 Spectroscopy market estimates, 2018 - 2030 (USD Million)
Fig. 15 Microscopy market estimates, 2018 - 2030 (USD Million)
Fig. 16 Chromatography market estimates, 2018 - 2030 (USD Million)
Fig. 17 Flow cytometry market estimates, 2018 - 2030 (USD Million)
Fig. 18 Sequencing market estimates, 2018 - 2030 (USD Million)
Fig. 19 Microarray market estimates, 2018 - 2030 (USD Million)
Fig. 20 Others market estimates, 2018 - 2030 (USD Million)
Fig. 21 Cell culture instruments market estimates, 2018 - 2030 (USD Million)
Fig. 22 Culture systems market estimates, 2018 - 2030 (USD Million)
Fig. 23 Incubators market estimates, 2018 - 2030 (USD Million)
Fig. 24 Cryostorage equipment market estimates, 2018 - 2030 (USD Million)
Fig. 25 Biosafety equipment market estimates, 2018 - 2030 (USD Million)
Fig. 26 Pipetting instruments market estimates, 2018 - 2030 (USD Million)
Fig. 27 Cell separation instruments market estimates, 2018 - 2030 (USD Million)
Fig. 28 Centrifuge market estimates, 2018 - 2030 (USD Million)
Fig. 29 Filtration systems market estimates, 2018 - 2030 (USD Million)
Fig. 30 Magnetic - activated cell separator systems market estimates, 2018 - 2030 (USD Million)
Fig. 31 Immnuoassay instruments market estimates, 2018 - 2030 (USD Million)
Fig. 32 Clinical chemistry analyzers market estimates, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates, 2018 - 2030 (USD Million)
Fig. 34 Global biotechnology instruments market: End - use outlook key takeaways
Fig. 35 Global biotechnology instruments market: End - use movement analysis
Fig. 36 Pharmaceutical & biotechnology companies market estimates, 2018 - 2030 (USD Million)
Fig. 37 Hospitals & diagnostic laboratories market estimates, 2018 - 2030 (USD Million)
Fig. 38 Academic & research institutes market estimates, 2018 - 2030 (USD Million)
Fig. 39 Others market estimates, 2018 - 2030 (USD Million)
Fig. 40 Regional marketplace: Key takeaways
Fig. 41 Global biotechnology instruments market: Regional movement analysis
Fig. 42 North America biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 43 U.S. biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 44 Canada biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 45 Europe biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 46 UK biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 47 Germany biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 48 France biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 49 Spain biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 50 Italy biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 51 Denmark biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 52 Sweden biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 53 Norway biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 54 Asia Pacific biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 55 Japan biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 56 China biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 57 India biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 58 South Korea biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 59 Australia biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 60 Thailand biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 61 Latin America biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 62 Brazil biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 63 Mexico biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 64 Argentina biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 65 MEA biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 66 South Africa biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 67 Saudi Arabia biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 68 UAE biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 69 Kuwait biotechnology instruments market, 2018 - 2030 (USD Million)
Fig. 70 Strategy framework

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Waters Corp.
  • Shimadzu Corp.
  • Danaher
  • Agilent Technologies, Inc.
  • Bruker Corp.
  • PerkinElmer, Inc.
  • Mettler Toledo
  • Zeiss Group
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Eppendorf SE
  • F. Hoffmann-La Roche AG
  • Sartorius AG
  • Avantor, Inc.

Methodology

Loading
LOADING...